Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model
Alba Di Pardo, Giuseppe Pepe, Salvatore Castaldo, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Functional roles of sphingolipids in immunity and their implication in disease
Mingyu Lee, Suh Yeon Lee, Yoe‐Sik Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1110-1130
Open Access | Times Cited: 64
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods
Daan van Kruining, Qian Luo, Gerhild van Echten‐Deckert, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 232-244
Open Access | Times Cited: 92
A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease
Kai-Po Chen, Kuo‐Feng Hua, Fu-Ting Tsai, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation
Hyunglok Chung, Qi Ye, Ye-Jin Park, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 855-874.e5
Open Access | Times Cited: 31
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
Yanhong Bu, Hong Wu, Ran Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Implications of Sphingolipids on Aging and Age-Related Diseases
Shengxin Li, Hyun-Eui Kim
Frontiers in Aging (2022) Vol. 2
Open Access | Times Cited: 28
Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease.
Francesca Elifani, Enrico Amico, Giuseppe Pepe, et al.
Human Molecular Genetics (2019)
Closed Access | Times Cited: 40
A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
Johannes Burtscher, Vittorio Maglione, Alba Di Pardo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 582-582
Open Access | Times Cited: 27
Review of Huntington’s Disease: From Basics to Advances in Diagnosis and Treatment
Natalia González Rojas, Martín Emiliano Cesarini, Guillermo Peker, et al.
Journal of Neurology Research (2022) Vol. 12, Iss. 3, pp. 93-113
Open Access | Times Cited: 19
Presymptomatic Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis
Ebenezer C Ikefuama, Ashley N. Slaviero, Alexander D. Silvagnoli, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112022-112022
Open Access
An unraveled mystery: What's the role of brain sphingolipids in neurodegenerative and psychiatric disorders
Xintian Bie, Min Zhang, Qingyu Wang, et al.
Neurobiology of Disease (2025) Vol. 207, pp. 106852-106852
Open Access
Sphingolipids and impaired hypoxic stress responses in Huntington disease
Johannes Burtscher, Giuseppe Pepe, Niran Maharjan, et al.
Progress in Lipid Research (2023) Vol. 90, pp. 101224-101224
Open Access | Times Cited: 10
Neurolipid systems: A new target for the treatment of dementia
Gorka Pereira‐Castelo, Iker Bengoetxea de Tena, Jonatan Martínez‐Gardeazabal, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 3, pp. 225-236
Open Access | Times Cited: 3
Intestinal aberrant sphingolipid metabolism shaped‐gut microbiome and bile acids metabolome in the development of hepatic steatosis
Rong‐Rong Miao, Sheng Zhan, Shu‐Xiang Cui, et al.
The FASEB Journal (2022) Vol. 36, Iss. 8
Closed Access | Times Cited: 15
Curcumin-Loaded Nanoparticles Based on Amphiphilic Hyaluronan-Conjugate Explored as Targeting Delivery System for Neurodegenerative Disorders
Giuseppe Pepe, Enrica Calce, Valentina Verdoliva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8846-8846
Open Access | Times Cited: 23
S1P/S1P Receptor Signaling in Neuromuscolar Disorders
Elisabetta Meacci, Mercedes Garcia‐Gil
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6364-6364
Open Access | Times Cited: 20
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
Alba Di Pardo, Elena Ciaglia, Monica Cattaneo, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 7
Open Access | Times Cited: 20
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease
Giuseppe Pepe, Luca Capocci, Federico Marracino, et al.
Molecular Therapy (2022) Vol. 31, Iss. 1, pp. 282-299
Closed Access | Times Cited: 11
Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
Johannes Burtscher, Alba Di Pardo, Vittorio Maglione, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5412-5412
Open Access | Times Cited: 15
Altered expression of glycobiology-related genes in Parkinson’s disease brain
Jay S. Schneider, Garima Singh
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Recent Insight into the Role of Sphingosine-1-Phosphate Lyase in Neurodegeneration
Iga Wieczorek, Robert P. Strosznajder
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6180-6180
Open Access | Times Cited: 4
The SphK1/S1P Axis Regulates Synaptic Vesicle Endocytosis via TRPC5 Channels
Zhong-Jiao Jiang, Liang‐Wei Gong
Journal of Neuroscience (2023) Vol. 43, Iss. 21, pp. 3807-3824
Open Access | Times Cited: 4
Stimulating the expression of sphingosine kinase 1 (SphK1) is beneficial to reduce acrylamide-induced nerve cell damage
Cuiping Yu, Yu-Lin Pan, Xiaoli Wang, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 237, pp. 113511-113511
Open Access | Times Cited: 7
Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease
Alba Di Pardo, Giuseppe Pepe, Luca Capocci, et al.
Neurobiology of Disease (2020) Vol. 143, pp. 105009-105009
Open Access | Times Cited: 9
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection
Gergely Imre, Verena Krähling, Madeleine Eichler, et al.
iScience (2021) Vol. 24, Iss. 4, pp. 102266-102266
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top